ClinicalTrials.Veeva

Menu

CoViD-19 Patient in Reims University Hospital in March to April 2020 (COVID-Reims)

C

CHU de Reims

Status

Completed

Conditions

Coronavirus Infections

Treatments

Biological: serology

Study type

Observational

Funder types

Other

Identifiers

NCT04553575
PO20124*

Details and patient eligibility

About

Medical context: Follow-up of a retrospective cohort of 499 cases of CoViD-19, hospitalized at the University Hospital of Reims during the health crisis, prospectively up to two years of follow-up.

Possible intervention for serological monitoring, leading to a change from category 3 to category 2 (French law on human person research)

Aim of the study: To know the factors of gravity of CoViD-19, to know its prognostic factors, to see how the evolution of the treatments implemented have influenced the fate of the patients.

Material and methods:

Type of study: cohort study Population: Patients in the CoViD-19 cohort - Reims Calendar: September 2020 - July 2022

Expected results: Better knowledge of the cares of patients with CoViD-19

Enrollment

127 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient hospitalized for CoViD-19 infection during the health crisis, in a short-stay service of Reims University Hospital and included in Covid-19 Cohort
  • Age > 18 years
  • Patient who benefit from the national health insurance coverage
  • patient agree for participation (consent form signed)

Exclusion criteria

  • Patient protected by law

Trial design

127 participants in 1 patient group

CoViD-19 patients cohort
Description:
Patients are followed for 2 years after diagnosis. The only one intervention is blood samples withdrawn for serologies
Treatment:
Biological: serology

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems